BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income4,920,0001,007,0004,457,0001,565,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation566,000339,000522,000568,000
Adjustments To Net Income278,0002,341,000-769,000707,000
Changes In Accounts Receivables-429,000-431,000-803,000-942,000
Changes In Liabilities25,000-322,00040,000-701,000
Changes In Inventories-216,000-29,000-152,00097,000
Changes In Other Operating Activities634,000-227,000216,000617,000
Total Cash Flow From Operating Activities5,940,0005,275,0003,058,0002,105,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-951,000-1,055,000-1,215,000-820,000
Investments74,000975,0001,720,000-349,000
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-874,000-66,0001,480,000-1,572,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid-2,613,000-2,577,000-2,547,000-2,477,000
Sale Purchase of Stock----
Net Borrowings-548,000991,000110,000-1,138,000
Other Cash Flows from Financing Activities-54,000-22,00015,000-9,000
Total Cash Flows From Financing Activities-3,535,000-4,077,000-2,653,000-3,624,000
Effect Of Exchange Rate Changes-41,00052,000-33,000-95,000
Change In Cash and Cash Equivalents1,490,0001,184,0001,852,000-3,186,000